Crossmark

Consequences of the COVID-19 pandemic on lung cancer care and patient health in a German lung cancer center: results from a cross-sectional questionnaire

Crossref DOI link: https://doi.org/10.1186/s12931-022-01931-z

Published Online: 2022-01-29

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Walter, Julia https://orcid.org/0000-0003-4304-6159
Sellmer, Laura

Kahnert, Kathrin

Kiefl, Rosemarie

Syunyaeva, Zulfiya

Kauffmann-Guerrero, Diego

Manapov, Farkhad

Schneider, Christian

Behr, Juergen

Tufman, Amanda
Funding

Funding for this research was provided by:

Takeda Pharma Vertrieb GmbH & Co. KG.

Ludwig-Maximilians-Universität München
License Information

Text and Data Mining valid from 2022-01-29

Version of Record valid from 2022-01-29
More Information

Article History

Received: 17 February 2021

Accepted: 10 January 2022

First Online: 29 January 2022

Declarations

:

: Approval for this prospective non-interventional study was obtained from the Ethics Committee of the Ludwig-Maximilians University. The study was conducted in accordance with the Declaration of Helsinki, Good Clinical Practice guidelines, and local ethical and legal requirements. Questionnaires, patient information and consent to participation forms were mailed out. Only questionnaires accompanied by a signed consent form were used for analysis in the study.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below